Demonstrating proof of concept for value-based agreements in Europe: two real-world cases

Author:

Griffiths Elizabeth A.ORCID,Odelade Onivefu E.,Gostkorzewicz Joana,Cordero Luis

Abstract

Abstract Objectives Value-based agreements (VBAs) link access, reimbursement, or price to the real-world usage and impact of a medicine, thereby enabling patient access while reducing clinical or financial uncertainty for the payer. VBAs have the potential to support improved patient outcomes, given the value-oriented approach to care, and lead to overall savings, while enabling payers to share risk and reduce uncertainty. Methods This commentary outlines the key challenges, enablers, and a framework for successful implementation by comparing the experience of two VBAs for AstraZeneca medicines, aiming to increase confidence in their future use. Results Engagement by payers, manufacturers, physicians, and provider institutions, and robust data collection systems that are accessible, simple to use, and add little burden to physicians were key to successfully negotiating a VBA that worked for all stakeholders. In both country systems, a legal/policy framework enabled innovative contracting. Conclusions These examples demonstrate proof of concept for VBA implementation in different settings, and may inform future VBAs.

Funder

AstraZeneca

Publisher

Cambridge University Press (CUP)

Subject

Health Policy

Reference12 articles.

1. Managed Entry Agreements: Policy Analysis From the European Perspective

2. Implementing Risk-Sharing Arrangements for Innovative Medicines: The Experience in Catalonia (Spain)

3. Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancer

4. Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis

5. 8. Appleby, J , Galea, A , Murray, R. [Internet] The NHS productivity challenge. Experience from the front line [cited 2022 Mar 4]. 2014. Available from: https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/the-nhs-productivity-challenge-kingsfund-may14.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3